Probiotics for preventing acute otitis media in children (Review)

Thumbnail Image
File version

Version of Record (VoR)

Scott, AM
Clark, J
Julien, B
Islam, F
Roos, K
Grimwood, K
Little, P
Del Mar, CB
Griffith University Author(s)
Primary Supervisor
Other Supervisors
File type(s)

Background: Acute otitis media (AOM), or acute middle ear infection, is one of the most frequently occurring childhood diseases, and the most common reason given for prescribing antibiotics in this age group. Guidelines often recommend antibiotics as first‐line treatment for severe AOM. However, antibiotics also lead to antibiotic resistance, so preventing episodes of AOM is an urgent priority.

Objectives: To assess the effects of probiotics to prevent the occurrence and reduce the severity of acute otitis media in children.

Search methods: We searched CENTRAL, PubMed, Embase, and three other databases (October 2018), two trial registers (October 2018), and conducted a backwards and forwards citation analysis (August 2018). We did not apply any language, publication date, or publication status restrictions.

Selection criteria: Randomised controlled trials (RCTs) of children (aged up to 18 years), comparing probiotics with placebo, usual care, or no probiotic.

Data collection and analysis Two review authors independently assessed the eligibility of trials for inclusion and risk of bias of the included trials, and extracted data using pre‐piloted data extraction forms. We analysed dichotomous data as either risk ratio (RR) or odds ratios (OR) and continuous data as mean differences (MD).

Main results: We included 17 RCTs involving 3488 children, of which 16 RCTs were included in the meta‐analyses. Of the 16 RCTs that reported the mean age of children, mean age overall was 2.4 years; in 4 RCTs the mean age of children participating in the trial was less than 1 year old; in 2 RCTs the mean age was between 1 and 2 years old; and in 10 RCTs the mean age was older than 2 years. Probiotic strains evaluated by the trials varied, with 11 of the included RCTs evaluating Lactobacillus‐containing probiotics, and six RCTs evaluating Streptococcus‐containing probiotics.

The proportion of children (i.e. the number of children in each group) experiencing one or more episodes of AOM during the treatment was lower for those taking probiotics (RR 0.77, 95% confidence interval (CI) 0.63 to 0.93; 16 trials; 2961 participants; number needed to treat for an additional beneficial outcome (NNTB) = 10; moderate‐certainty evidence).

Post hoc subgroup analysis found that among children not prone to otitis media, a lower proportion of children receiving probiotics experienced AOM (RR 0.64, 95% CI 0.49 to 0.84; 11 trials; 2227 participants; NNTB = 9; moderate‐certainty evidence). However, among children who were otitis prone, there was no difference between probiotic and comparator groups (RR 0.97, 95% CI 0.85 to 1.11; 5 trials; 734 participants; high‐certainty evidence). The test for subgroup differences was significant (P = 0.007).

None of the included trials reported on the severity of AOM.

The proportion of children experiencing adverse events did not differ between the probiotic and comparator groups (OR 1.54, 95% CI 0.60 to 3.94; 4 trials; 395 participants; low‐certainty evidence).

Probiotics decreased the proportion of children taking antibiotics for any infection (RR 0.66, 95% CI 0.51 to 0.86; 8 trials; 1768 participants; NNTB = 8; moderate‐certainty evidence). Test for subgroup differences (use of antibiotic specifically for AOM, use of antibiotic for infections other than AOM) was not significant.

There was no difference in the mean number of school days lost (MD −0.95, 95% CI −2.47 to 0.57; 5 trials; 1280 participants; moderate‐certainty evidence). There was no difference between groups in the level of compliance in taking the intervention (RR 1.02, 95% CI 0.99 to 1.05; 5 trials; 990 participants).

Probiotics decreased the proportion of children having other infections (RR 0.75, 95% CI 0.65 to 0.87; 11 trials; 3610 participants; NNTB = 12; moderate‐certainty evidence). Test for subgroup differences (acute respiratory infections, gastrointestinal infections) was not significant.

Probiotic strains trialled and their dose, frequency, and duration of administration varied considerably across studies, which likely contributed to the substantial levels of heterogeneity. Sensitivity testing of funnel plots did not reveal publication bias.

Authors' conclusions: Probiotics may prevent AOM in children not prone to AOM, but the inconsistency of the subgroup analyses suggests caution in interpreting these results. Probiotics decreased the proportion of children taking antibiotics for any infection. The proportion of children experiencing adverse events did not differ between the probiotic and comparator groups. The optimal strain, duration, frequency, and timing of probiotic administration still needs to be established.

Journal Title

Cochrane Database of Systematic Reviews

Conference Title
Book Title




Thesis Type
Degree Program
Publisher link
Patent number
Grant identifier(s)
Rights Statement
Rights Statement

© 2019 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd. This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD012941. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.

Item Access Status
Access the data
Related item(s)

Biomedical and clinical sciences

Clinical sciences


Health sciences

Science & Technology

Life Sciences & Biomedicine

Medicine, General & Internal

General & Internal Medicine


Persistent link to this record

Scott, AM; Clark, J; Julien, B; Islam, F; Roos, K; Grimwood, K; Little, P; Del Mar, CB, Probiotics for preventing acute otitis media in children (Review), Cochrane Database of Systematic Reviews, 2019, 2019 (6)